2022 Letters to Congress and federal agencies

• APHA letter to the U.S. Senate in support of S. J. Res. 56, the war powers resolution that would end any unauthorized U.S. military support of the Saudi Arabian-led war in the Republic of Yemen (Dec. 13)
• APHA letter to Secretary of State Blinken regarding the arrest of Turkish Medical Association president Fincancı (Dec. 7)

• Friends of HRSA letter to appropriations leaders in support of at least $9.39 billion in funding for HRSA in any final FY 2023 spending bill (Nov. 30)
• Health, education and human services organization letter in support of the Respect for Marriage Act (Nov. 15) 
• CDC Coalition letter to House and Senate Appropriations Committee leaders in support of at least $10.45 billion in funding for CDC in any final FY 2023 spending bill (Nov. 11)

No letters

• Organization letter to the Department of Health and Human Services commending their action on promoting voting access and providing further recommendations for prioritizing voting (Sept. 19) 

• Organization letter urging mental health as a priority in the new Administration for Strategic Preparedness and Response (Aug. 25)
• APHA letter to the U.S. Senate in support of the Inflation Reduction Act (Aug. 5)
• Health organization letter to U.S. EPA in support of strong final cleaner car standards (Aug. 4)

• APHA letter to the U.S. House of Representatives in support of H.R. 8296, the Women’s Health Protection Act of 2022 and H.R. 8297, the Ensuring Access to Abortion Act of 2022 (July 12)

• Health organization letter to EPA Administrator Regan urging EPA to promulgate stronger National Ambient Air Quality Standards for particulate matter pollution (June 27)
• APHA letter to the U.S. House of Representatives in support of the Bipartisan Safer Communities Act (June 24)
• APHA letter to the U.S. Senate in support of the Bipartisan Safer Communities Act (June 23)
• Organization letter in support of H.R. 4176, the LGBTQI+ Data Inclusion Act (June 14)
• APHA letter to the U.S. House of Representatives in support of H.R. 7910, the Protecting Our Kids Act and H.R. 2377, the Federal Extreme Risk Protection Order Act (June 7)
• Organization letter to House and Senate Labor-HHS-Education appropriations subcommittee leaders in support of $153 million for CDC's Social Determinants of Health program in FY 2023 (June 1)

• Organization letter to House and Senate Labor-HHS-Education appropriations subcommittee leaders in support of provide at least $375.3 million for NIOSH in the FY 2023 Labor-HHS-Education appropriations bill (May 31)
• APHA letter in support of the Alan Reinstein Ban Asbestos Now Act (May 26)
• Organization letter to House and Senate Labor-HHS-Education appropriations subcommittee leaders in support of the comprehensive pandemic preparedness and biodefense funding request included in the FY 2023 president’s budget request (May 24)
• Health and medical organization letter to all members of Congress in support of strong climate change and clean energy investments this year (May 20)
• Organization letter to House and Senate leadership in support of legislation to provide federal agencies with the flexibilities and funding needed to shore up supply and assure the safety of infant formula available on the market (May 18)
• Organization letter to House and Senate Appropriations Committee leaders in support of $100 million for the Centers for Disease Control and Prevention’s Agency for Toxic Substances and Disease Registry in the FY 2023 Interior, Environment, and Related Agencies Appropriations bill (May 17)
• Organization letter to the Department of Health and Human Services urging that the administration maintain the Public Health Emergency status until the pandemic recedes (May 10)
• Organization letter to the Senate urging support for S. 4132, the Women’s Health Protection Act of 2022 (May 9)
• Organization letters to House and Senate Appropriations Committee leaders in support of strong FY 2023 funding for OSHA and NIOSH (May 2)

• Organization letter to House and Senate Interior-Environment appropriations subcommittee leaders urging full funding of the president’s FY 2023 budget request for EPA's implementation of the Toxic Substances Control Act (April 29)
• Letter from 288 medical, public health, and research organizations in support of FY 2023 funding of $35 million for CDC and $25 million for NIH to conduct public health research into firearm morbidity and mortality prevention (April 28)
• Organization letter to Senate Appropriations Committee leaders in support of adequate funding and staff resources for the U.S. Department of Transportation and its safety agencies (April 27)
• Organization letter to Congress urging replenishment of HRSA's COVID-19 Uninsured Relief Fund (April 27)
• Dear Colleague endorsed by APHA to appropriations leaders in support of FY23 funding for maternal health programs at CDC, HRSA and NIH (April 27)
• Organization letter to appropriations leaders in support of FY23 funding for programs enacted by the Maternal Health Quality Improvement Act and the Rural Maternal and Obstetric Modernization of Services Act (April 27)
• Organization letter to Congress opposing any extension of restrictions on asylum seekers under the Title 42 policy (April 26)
• Organization letter in support of at least $250 million for a new Community Violence Intervention Initiative at CDC in the FY 2023 Labor, Health and Human Services, Education & Related Agencies Appropriations bill (April 25)
• Organization letter to appropriations leaders urging increased funding for international family planning and reproductive health programs (April 21)
• Health organization letter to the House and Senate Interior, Environment and Related Agencies Appropriations Subcommittee in support of $11.9 billion in FY 2023 for the U.S. Environmental Protection Agency (April 20)
• Organization letter to CMS in support of actions to prevent people eligible for insurance affordability programs from losing coverage and care when the current public health emergency ends (April 20)
• Organization letters to House and Senate appropriations leaders urging increased funding for CDC's Office on Smoking and Health in FY23 (April 18)
• Organization letter in support of $110 million for CDC's Climate and Health Program in FY 2023 (April 8)
• Organization letters to Congress urging action on mental health and wellbeing legislative priorities and appropriations priorities (April 6)
• Friends of HRSA coalition letter to House and Senate Labor-HHS-Education Appropriations Subcommittee leaders in support of $9.8 billion in funding for HRSA in FY 2023 (April 6)
• CDC Coalition letter to House and Senate Labor-HHS-Education Appropriations Subcommittee leaders in support of $11 billion in funding for CDC in FY 2023 (April 1)

• APHA letter to congressional leaders in support of additional emergency supplemental appropriations for COVID-19 prevention and response activities (March 17)
• Organization letter to Congress endorsing H.R. 7105, the Sober Truth on Preventing (STOP) Underage Drinking Act (March 17)
• Organization letter to Congress urging statutory clarification of the U.S. Food and Drug Administration's authority over synthetic nicotine products (March 7)

• APHA letter to the Senate urging support for the Women's Health Protection Act to create a federal, statutory right to abortion (Feb. 28)
• Organization letter to Congress in support of the Job Protection Act, which would expand Family and Medical Leave Act protections to part-time employees and employees of small employers (Feb. 23)
• Organization letter in support of the House-passed FY 2022 level for CDC's National Center for Injury Prevention and Control (Feb. 22)
• National organization statement opposing state-level anti-LGBTQ+ legislation (Feb. 15)
• Organization letter to Congress in support of the climate change and clean energy provisions included in the House-passed Build Back Better Act (Feb. 9)
• Organization letter in support of including S. 3534, the Tracking Pathogens Act in the PREVENT Pandemics Act discussion draft (Feb. 4)
• Organization statement in support of Medicare coverage for medically-necessary oral/dental health therapies (Feb. 2022)